These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26383155)

  • 1. Prolonged Antimuscarinic Delirium in a Child Due to Benztropine Exposure Treated With Multiple Doses of Physostigmine.
    Thornton SL; Farnaes L; Minns A
    Pediatr Emerg Care; 2016 Apr; 32(4):243-5. PubMed ID: 26383155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful management of olanzapine-induced anticholinergic agitation and delirium with a continuous intravenous infusion of physostigmine in a pediatric patient.
    Hail SL; Obafemi A; Kleinschmidt KC
    Clin Toxicol (Phila); 2013 Mar; 51(3):162-6. PubMed ID: 23473460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine is superior to non-antidote therapy in the management of antimuscarinic delirium: a prospective study from a regional poison center.
    Boley SP; Olives TD; Bangh SA; Fahrner S; Cole JB
    Clin Toxicol (Phila); 2019 Jan; 57(1):50-55. PubMed ID: 29956570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physostigmine for Antimuscarinic Toxicity.
    Saadi R; Bohnenberger K
    J Emerg Nurs; 2020 Jan; 46(1):126-128. PubMed ID: 31918808
    [No Abstract]   [Full Text] [Related]  

  • 6. A randomized trial comparing physostigmine vs lorazepam for treatment of antimuscarinic (anticholinergic) toxidrome.
    Wang GS; Baker K; Ng P; Janis GC; Leonard J; Mistry RD; Heard K
    Clin Toxicol (Phila); 2021 Aug; 59(8):698-704. PubMed ID: 33295809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous infusion of physostigmine in anticholinergic delirium: case report.
    Stern TA
    J Clin Psychiatry; 1983 Dec; 44(12):463-4. PubMed ID: 6654839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivastigmine Use in the Treatment of Antimuscarinic Delirium.
    Greene SC
    J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of a physostigmine continuous infusion for the treatment of severe and recurrent antimuscarinic toxicity in a mixed drug overdose.
    Phillips MA; Acquisto NM; Gorodetsky RM; Wiegand TJ
    J Med Toxicol; 2014 Jun; 10(2):205-9. PubMed ID: 24798647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physostigmine reversal of delirium from second generation antipsychotic exposure: a retrospective cohort study from a regional poison center.
    Arens AM; Sheikh Said H; Driver BE; Cole JB
    Clin Toxicol (Phila); 2024 Jul; 62(7):463-467. PubMed ID: 38984853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comparison of Resource Utilization in the Management of Anticholinergic Delirium Between Physostigmine and Nonantidote Therapy.
    Boley SP; Stellpflug SJ
    Ann Pharmacother; 2019 Oct; 53(10):1026-1032. PubMed ID: 31023063
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing and frequency of physostigmine redosing for antimuscarinic toxicity.
    Rosenbaum C; Bird SB
    J Med Toxicol; 2010 Dec; 6(4):386-92. PubMed ID: 20405266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benztropine abuse and overdose--case report and review.
    Grace RF
    Adverse Drug React Toxicol Rev; 1997 Jun; 16(2):103-12. PubMed ID: 9359932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events from physostigmine: An observational study.
    Nguyen TT; Armengol C; Wilhoite G; Cumpston KL; Wills BK
    Am J Emerg Med; 2018 Jan; 36(1):141-142. PubMed ID: 28716594
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning.
    Burns MJ; Linden CH; Graudins A; Brown RM; Fletcher KE
    Ann Emerg Med; 2000 Apr; 35(4):374-81. PubMed ID: 10736125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physostigmine Reversal of Dysarthria and Delirium After Iatrogenic Atropine Overdose From a Dental Procedure.
    Cole JB; Orozco BS; Arens AM
    J Emerg Med; 2018 Jun; 54(6):e113-e115. PubMed ID: 29681419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications of diagnostic physostigmine administration to emergency department patients.
    Schneir AB; Offerman SR; Ly BT; Davis JM; Baldwin RT; Williams SR; Clark RF
    Ann Emerg Med; 2003 Jul; 42(1):14-9. PubMed ID: 12827117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting injectable olanzapine can give rise to a condition consistent with central anticholinergic syndrome.
    Skomedal T; Hanem S; Dybvik T; Ilner SO
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2238-9. PubMed ID: 24226327
    [No Abstract]   [Full Text] [Related]  

  • 19. Shortages of agents used to treat antimuscarinic delirium.
    Whitledge JD; Soto P; Glowacki KM; Fox ER; Mazer-Amirshahi M
    Am J Emerg Med; 2023 May; 67():163-167. PubMed ID: 36893630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of physostigmine: a 10-year retrospective review.
    Arens AM; Shah K; Al-Abri S; Olson KR; Kearney T
    Clin Toxicol (Phila); 2018 Feb; 56(2):101-107. PubMed ID: 28703024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.